-
Phaeochromocytomas are neuroendocrine tumours of the adrenal medulla
-
10% multiple
-
10% extra-adrenal
-
10% malignant
-
Extra-adrenal tumours are called paraganglionomas
-
Most secrete adrenaline
-
Some secrete noradrenaline and dopamine
-
Clinical effects are due catecholamine excess
Clinical features
-
Phaeochromocytomas account for 0.1% cases of hypertension
-
Symptoms are often sporadic and paroxysmal
-
Attacks may last minutes or hours and occur at variable intervals
-
Include hypertension, palpitations, tachycardia and sweating
-
50% of patients develop chest pain
-
Chronic effects include hypovolaemia and cardiomyopathy
-
Phaeochromocytomas can be associated with:
Investigations


Picture provided by Suzanne Yoder, UCSD Medical Centre, San Diego, USA
Management
-
Clinical features can not be controlled pharmacologically
-
Need adrenalectomy after appropriate preoperative preparation
-
Requires close cooperation between surgeon and anaesthetist
-
Preoperative preparation requires:
-
Alpha-blockade with phenoxybenzamine for at least 2 weeks preoperatively
-
Volume expansion with intravenous fluids
-
Beta-blockade after alpha-blockade
-
Beta-blockade without alpha-blockade can cause a hypertensive crisis
-
Intraoperative problems include:
-
Intraoperative blood pressure control achieved with fluids, nitroprusside and dopamine infusions

Picture provided by David Martin, Princess Alexandra Hospital, Brisbane, Australia
Bibliography
Lenders J W, Eisenhofer G, Mannelli M et
al. Phaeochromocytoma. Lancet 2005; 366:
665-675.
Peplinski G R, Norton J A.
The predictive value of diagnostic tests for phaeochromocytoma. Surgery
1994; 116: 1101-1110.
Roman S. Phaeochromocytoma and functional paraganglioma. Curr Opin Oncol 2004;
16: 8-12.
Williams D T, Dann S, Wheeler M H. Phaeochromocytoma - views on current management. EJSO
2003; 29: 483-490.
|